Latest News and Press Releases
Want to stay updated on the latest news?
-
-
-
MONTRÉAL, QUÉBEC--(Marketwired - 22 sept. 2017) - N'EST PAS DESTINÉ À LA DISTRIBUTION AUX AGENCES DE PRESSE AMÉRICAINES NI À LA DIFFUSION AUX...
-
MONTREAL, QUEBEC--(Marketwired - Sept. 22, 2017) - NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES Pediapharm Inc. (TSX...
-
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Company announcement - No. 46 / 2017 ...
-
VALLEY COTTAGE, New York, Sept. 21, 2017 (GLOBE NEWSWIRE) -- Future Market Insights presents a revised forecast of the global animal healthcare market for a 10 year period 2017 – 2027. According...
-
Albany - NY, Sept. 21, 2017 (GLOBE NEWSWIRE) -- Serving to majorly fuel the global market for Nanoemulsion is the rapid technological progress in the pharmaceutical and biotechnology industry,...
-
Ocean View, Delaware, Sept. 21, 2017 (GLOBE NEWSWIRE) -- Antidiabetics Market is poised to reach USD 110 billion by 2024; according to a new research report by Global Market Insights, Inc....
-
Sanofi et Alnylam rapportent les premiers résultats positifs de l'étude de phase 3 APOLLO consacrée au patisiran dans le traitement de la polyneuropathie amyloïde familiale à la transthyrétine -...
-
Sanofi and Alnylam Report Positive Topline Results from APOLLO Phase 3 Study of Patisiran in Hereditary ATTR (hATTR) Amyloidosis Patients with Polyneuropathy - Investigational RNAi Therapeutic...